Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2025-02-28
• Last 15 days FTD volume: £0.01 M
• Last 3 months FTD volume: £0.27 M
• Last year FTD volume: £0.27 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	£0.14 B	£0.24 B	🇬🇧 UK
Sanofi SNY	£0.96 M	£47.53 M	🇫🇷 France
Biogen BIIB	£26.58 M	£75.58 M	🇺🇸 USA
AstraZeneca AZN	£24.59 M	£0.13 B	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	£9.55 M	£33.31 M	🇺🇸 USA
Sangamo Therapeutics SGMO	£1.19 M	£6.43 M	🇺🇸 USA
Bristol-Myers Squibb BMY	£0.17 B	£0.49 B	🇺🇸 USA